DSG Capital Advisors’s Medtronic MDT Stock Holding History

DSG Capital Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$233K	Buy	+2,686	New	+$257K	0.04%	119

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSG Capital Advisors's MDT Position: Q1 2026 in Review

DSG Capital Advisors opened a new position in Medtronic (MDT) in Q1 2026: 2,686 shares worth $233K. The stake represents 0.04% of the portfolio and ranks #119 among its holdings.

2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

DSG Capital Advisors held 2,686 shares of Medtronic worth $233K as of Q1 2026.
Medtronic was a new DSG Capital Advisors position in Q1 2026.
Medtronic made up 0.04% of DSG Capital Advisors's portfolio in Q1 2026, its #119 holding.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on DSG Capital Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.